Neuropediatrics 2009; 40(3): 120-125
DOI: 10.1055/s-0029-1243167
Original Article

© Georg Thieme Verlag KG Stuttgart · New York

Epilepsy in Patients with Propionic Acidemia

E. Haberlandt1 , C. Canestrini1 , M. Brunner-Krainz2 , D. Möslinger3 , K. Mussner4 , B. Plecko2 , S. Scholl-Bürgi1 , W. Sperl5 , K. Rostásy1 , D. Karall1
  • 1Clinical Department of Pediatrics, Division of Neonatology, Neuropediatrics and Inherited Metabolic Diseases, Medical University of Innsbruck, Innsbruck, Austria
  • 2University Children's Hospital Graz, Graz, Austria
  • 3University Children's Hospital Vienna, Vienna, Austria
  • 4Clinical Department of Pediatrics, Hospital Sterzing, Sterzing, Italy
  • 5Clinical Department of Pediatrics, Paracelsus University, Salzburg, Austria
Further Information

Publication History

received 01.05.2009

accepted 27.10.2009

Publication Date:
17 December 2009 (online)

Abstract

Propionic acidemia (PA) is an autosomal recessively inherited defect of propionyl-CoA carboxylase with an incidence of approximately 1:50 000. There are few reports on the occurrence of EEG findings and development of epilepsy in patients with PA. Retrospectively, the data of 17 patients with PA from one Italian and four Austrian centers were evaluated concerning EEG findings and the development of epilepsy. Nine patients showed a disturbance of background activity, as well as epileptiform discharges. All nine patients with pathological EEG discharges developed seizures compatible with the definition of symptomatic epilepsy. Five of these nine patients showed fever induced seizures at the beginning. Two of them suffered from symptomatic absence epilepsy. Six of the nine patients with seizures were treated with antiepileptic drugs (AED), which were tolerated without side-effects. Four patients showed photosensitivity, which so far has never been reported in PA. We hypothesize that patients with PA are prone to cortical dysfunction caused by one or several pathological metabolites – leading to changes in background and epileptiform activity with a high manifestation rate of clinical seizures.

References

  • 1 Baumgartner C. Handbuch der Epilepsien: Klinik, Diagnostik, Therapie und Psychosoziale Aspekte. 1st ed. Vienna, Springer Verlag 2001 15 and 36
  • 2 Baumgartner D, Scholl-Buergi S, Sass JO. et al . Prolonged QTc intervals and decreased left ventricular contractility in patients with propionic acidemia.  J Pediatr. 2007;  150 192-197
  • 3 Commission on Classification Terminology of the International League against Epilepsy . Proposal for revised classification of epilepsies and epileptic syndromes.  Epilepsia. 1989;  30 389-399
  • 4 Danober L, Deransart C, Depaulis A. et al . Pathophysiological mechanisms of genetic absence epilepsy in the rat.  Prog Neurobiol. 1998;  55 27-57
  • 5 Deodato F, Boenzi S, Santorelli FS. et al . Methylmalonic and propionic aciduria.  Am J Med Genet C Semin Med Genet. 2006;  142C 104-112
  • 6 Fenton WA, Gravel WA, Rosenblatt DS. Disorders of propionate and methylmalonate metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Diseases. 8th ed. New York: McGraw-Hill 2001: 2165-2193
  • 7 Futatsugi Y, Riviello  Jr  JJ. Mechanisms of generalised absence epilepsy.  Brain Dev. 1998;  20 75-79
  • 8 Haas RH, Marsden DL, Capistrano-Estrado S. et al . Acute basal ganglia infarction in propionic acidemia.  J Child Neurol. 1995;  10 18-22
  • 9 Haberlandt E, Scholl-Bürgi S, Haffner B †. et al . EEG-Veränderungen bei metabolischen Erkrankungen im Kindesalter. Mitteilungen der österreichischen Sektion der Liga gegen Epilepsie.  2005;  5 16-22 http://www.kup.at/journals/inhalt/842.html
  • 10 Lehnert W, Sperl W, Suormala T. et al . Propionic acidaemia: clinical, biochemical and therapeutic aspects. Experience in 30 patients.  Eur J Pediatr. 1994;  153 ((Suppl 1)) 68-80
  • 11 Malfatti CR, Perry ML, Schweigert ID. et al . Convulsions induced by methylmalonic acid are associated with glutamic acid decarboxylase inhibition in rats: a role for GABA in the seizures presented by methylmalonic acidemia patients?.  Neuroscience. 2007;  146 1879-1887
  • 12 Markand ON. Electroencephalography in diffuse Encephalopathies.  J Clin Neurophysiol. 1984;  1 357-407
  • 13 Muro S, Rodríguez-Pombo P, Pérez B. et al . Identification of novel mutations in the PCCB gene in European propionic acidemia patients Mutation in brief no. 253.  online.  Human Mutat. 1999;  14 89-90
  • 14 North KN, Korson MS, Gopal YR. et al . Neonatal-onset propionic acidemia: neurologic and developmental profiles, and implications for management.  J Pediatr. 1995;  126 916-922
  • 15 Nyhan WL, Bay C, Webb Beyer E. et al . Neurologic nonmetabolic presentation of propionic academia.  Arch Neurol. 1999;  56 1143-1147
  • 16 Pérez B, Desviat LR, Rodríguez-Pombo P. et al . Propionic acidemia: identification of twenty-four novel mutations in Europe and North America.  Mol Genet Metab. 2003;  78 59-67
  • 17 Plecko B, Brunner-Krainz M, Gruber-Sedlmayr U. et al . Epilepsie als Leitsymptom angeborener Stoffwechselstörungen. Mitteilungen der österreichischen Sektion der Liga gegen Epilepsie.  2005;  5 2-11 http://www.kup.at/journals/inhalt/842.html
  • 18 Rigo FK, Pasquetti L, Malfatti CR. et al . Propionic acid induces convulsions and protein carbonylation in rats.  Neurosci Lett. 2006;  13 (408) 151-154
  • 19 Sass JO, Hofmann M, Skladal D. et al . Propionic acidemia revisited: a workshop report.  Clin Pediatr (Phila). 2004;  43 837-843
  • 20 Stöckler S, Slavc I, Ebner F. et al . Asymptomatic lesions of the basal ganglia in a patient with methylmalonic aciduria.  Eur J Pediatr. 1992;  151 920
  • 21 Sweetman L, Williams JC. Branched chain organic acidurias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Iinherited Disease 8th ed. New York: McGraw-Hill 2001 pp 2125-2163
  • 22 Wendel U. Ogier de Baulny H. Branched-chain organic acidurias/acidemias. In: Fernandes J, Saudubray JM, van den Berghe G, Walter H, eds. Inborn Metabolic Diseases 4th ed. Berlin, Heidelberg, New York: Springer 2006 pp 245-262
  • 23 Wolf B, Hsia YE, Sweetman L. et al . Propionic acidemia: a clinical update.  J Pediatr. 1981;  99 835-846
  • 24 Wolf B, Paulsen EP, Dreifuss FE. Valproate in the Treatment of seizures associated with propionic acidemia.  Pediatrics. 1981;  67 162-163
  • 25 Wolf NI, Bast T, Surtees R. Epilepsy in inborm errors of metabolism.  Epileptic Disord. 2005;  7 67-81
  • 26 Wolf P, Gooses R. Relation of photosensitivity of epileptic syndromes.  J Neurol Neurosurg Psychiatry. 1986;  49 1386-1391
  • 27 Zschocke S. Klinische Elektroencephalographie 2nd ed. Springer Verlag 2002 p 204-207

Correspondence

Dr. Edda Haberlandt

Clinical Department of Pediatrics

Division of Neuropediatrics and Inherited Metabolic Diseases

Medical University Innsbruck

Anichstraße 35

6020 Innsbruck

Austria

Phone: +43/512/504 236 00

Fax: +43/512/504 232 47

Email: edda.haberlandt@uki.at

    >